Hybrid closed-loop insulin delivery provided better glucose control than sensor-augmented pump therapy with less risk of hypoglycemia in patients with suboptimally controlled type 1 diabetes, reported a Lancetstudy. Sensor-augmented pump therapy transmits glucose readings to the patient, who then makes decisions about insulin dosing. Hybrid closed-loop artificial pancreas systems use an algorithm to automate insulin delivery while giving patients some control.
Slomski A. Artificial Pancreas Improves Glycemic Control. JAMA. 2018;320(20):2068. doi:10.1001/jama.2018.18512
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: